Medical network - March 15 recently, health care do release in fujian province on the released drug joint limit sunlight procurement directory (first batch) and health care the highest selling price and payment settlement price notice. According to fujian province health care for medicare drug released after payment settlement price formulation principle, catalogue of drugs to be included in the 2017 edition of national health insurance (hereinafter referred to as "the new directory") varieties, to give by the regulation pay medical insurance fund, there are indications for the new directory limit range, to give pay only in limited within the scope of use; Beyond the pay, health care as a whole fund does not grant to pay.
However, the reporter discovers after combing, 1719 varieties in the fujian province medical insurance payment and settlement of centralized purchasing price is 0, 1437 varieties, including chemical drugs, Chinese patent medicine varieties, 282, and the variety and the new directory comparison after you can see, the new directory supplemented varieties there are quite a few did not enter the fujian in the directory, even after bidding quotation, enter in the directory also has not been paid, the results can not help moving.
Health care area differentiation goes up
People club department released in late February 2017, the new medical insurance directory, western medicine and traditional part contains 2535 drugs, from the 2009 version of the directory increased by 339, rising by about 15.4%, in which part of the western medicine, 1297, 1238 proprietary Chinese medicine section, it is national health care medicine directory in for the first time in eight years. The centralized procurement catalogue of fujian and health insurance payment standard, formally make fujian the first executive provinces of the latest medical insurance directory.
Contrast in fujian province, found that the new directory, the varieties of the new directory, small bupleurum decoction pill, strong, become pipagao in core particles, compound fresh bamboo liquid, pediatric seven-star tea oral liquid, only blindly pill varieties such as traditional Chinese medicines, and of doxycycline, ring serine, pemetrexed, western medicine varieties, such as cloth, he has appeared in fujian in the directory.
Honorary President of the association of business management of Chinese medicine ming-de yu pointed out in an interview that health care is the core principle of balance of payments, "how much money do how many thing", emphasis on health care around the can pay according to the local ability to raise funds to develop health standards. "Drug prices high nature has its rationality, also has its own reasons for low prices, free competitive pricing, this is the market, but the high price does not necessarily paid more, low price does not necessarily care can save money! Some species in different areas also can not get paid for differentiation may happen."
Comb reporter in 1719 in fujian medical insurance payment settlement price of 0 product rules found that 62 varieties: product gauge belongs to the new directory to 23 change rules belong to afar ossification alcohol, drug, top ketone, menadione, card the front element, mifepristone, thymus new and fat emulsion, the 39 compounds rules belong to notoginseng saponin oral preparations, available kyushin pills, xiang Dan injection, infantile diarrhea paste, ginkgo biloba oral preparations and zhengqin FengTongNing capsule (piece).
Since it will be on September 22, 2016, fujian province power integrate all medical and health related management department, establishment of medical security management committee of fujian province (there are health department), since in the past "Kowloon water conservancy" the situation is changed, the drug centralized purchasing on the basis of the medical insurance payment, strictly implement according to the general idea of the standard for payment, the method and content model is likely to cause other provinces to follow up and follow, this system also caused concern about a industry change.
Type "monster" will be hit
It is worth noting that in 1719 in fujian medical insurance payment settlement price of 0 product rules of dosage forms for special varieties can be said to focus, many soft capsules, tablets, effervescent tablets to give health care to pay. The personage inside course of study says, fujian in medicare payments has obvious policy guidance, namely to oral preparations, contain "strange", encourage enterprises to competition. "Some does not have the clinical value of improved, no clinical advantage of varieties of specifications, certainly will be eliminated gradually in the market competition, but also in fujian province in terms of price pressure too low, especially some varieties medicare payment settlement price is too low, for the imported drugs, the original quality branded drugs, domestic will form a certain degree."
In fact, the new directory supplement dosage forms of special varieties, there are a number of laissez faire in fujian in directory: sweet sand nourishing the stomach pills, granules, capsules, tablets) of fujian health highest sales price and payment settlement price is 1.1742 yuan, nourishing the stomach and supplement the new directory incense sand soft capsule has not appeared in fujian procurement directory; Qing ling granules (capsule, tablet, injection) of fujian health highest selling price and payment and settlement price is 3.5068 yuan, the new directory clear open spirit of supplementary soft capsule also did not appear in the fujian procurement directory; Qi chrysanthemum rehmannia pill (capsules, tablets) (in) of fujian/qi were used oral liquid (new catalogue), compound salvia miltiorrhiza granule, capsule, tablet, pill, dropping pill) (in) of fujian/compound salvia miltiorrhiza spray (new catalogue), bolted pill (capsule, soft capsule) (in) of fujian/bolted together dropping pill (new catalogue)... There are many similar situation.
Above the personage inside course of study further points out, "according to the 'four general formulation of therapeutic drugs, auxiliary medication and nutritional medicine will further aggravate the price competition. Medical insurance payment system should be encouraged to increase the variety of clinical treatment options, meet diversified, different levels of doctors, patients, medical needs, some varieties specifications price is too low, drug companies can't accept bargain with quantity, species are likely to disappear in clinic."
"Paid price must not be set at the lowest price, also can't set in the highest, and should be in the middle of a moderate price, payment standard has nothing to do with buying and selling prices, health care departments do not think that the national development and reform commission release part of drug prices, they can to tube, this is not suitable for." Ming-de yu believes that patients can choose paid varieties, can also choose to part of a large variety, hospitals should guarantee the supply, payment but obviously the new health care reform will further aggravate among patients with medical care, drug companies, three of the game. |
